Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study

Bibliographic Details
Title: Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study
Authors: Juha Hartikainen, Jukka Putaala, Jari Haukka, Fausto Biancari, Pirjo Mustonen, Miika Linna, Konsta Teppo, Jussi Jaakkola, Olli Halminen, Janne Kinnunen, Mika Lehto, Alex Luojus, Saga Itäinen-Strömberg, Tero Penttilä, Mikko Niemi, KE Juhani Airaksinen
Source: BMJ Open, Vol 12, Iss 8 (2022)
Publisher Information: BMJ Publishing Group, 2022.
Publication Year: 2022
Collection: LCC:Medicine
Subject Terms: Medicine
More Details: Objectives Mental health conditions (MHCs) have been associated with undertreatment of unrelated medical conditions, but whether patients with MHCs face disparities in receiving rhythm control therapies for atrial fibrillation (AF) is currently unknown. We assessed the hypothesis that MHCs are associated with a lower use of antiarrhythmic therapies (AATs).Design A nationwide retrospective registry-based cohort study.Setting The Finnish AntiCoagulation in Atrial Fibrillation cohort included records on all patients with AF in Finland during 2007–2018 identified from nationwide registries covering all levels of care as well as drug purchases. MHCs of interest were diagnosed depression, bipolar disorder, anxiety disorder, schizophrenia and any MHC.Participants We identified 239 222 patients (mean age 72.6±13.2 years; 49.8% women) with incident AF, in whom the prevalence of any MHC was 19.9%.Outcomes Primary outcome was use of any AAT, including cardioversion, catheter ablation, and fulfilled antiarrhythmic drug (AAD) prescription.Results Lower overall use of any AAT emerged in patients with any MHC than in those without MHC (16.9% vs 22.9%, p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2044-6055
Relation: https://bmjopen.bmj.com/content/12/8/e059759.full; https://doaj.org/toc/2044-6055
DOI: 10.1136/bmjopen-2021-059759
Access URL: https://doaj.org/article/cf6f94daeffd4a9296e9bf5959d9cf25
Accession Number: edsdoj.f6f94daeffd4a9296e9bf5959d9cf25
Database: Directory of Open Access Journals
More Details
ISSN:20446055
DOI:10.1136/bmjopen-2021-059759
Published in:BMJ Open
Language:English